Striatal TRPV1 activation by acetaminophen ameliorates dopamine D2 receptor antagonist-induced orofacial dyskinesia. 2021

Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
Department of Molecular Pharmacology, Graduate School and Faculty of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.

Antipsychotics often cause tardive dyskinesia, an adverse symptom of involuntary hyperkinetic movements. Analysis of the US Food and Drug Administration Adverse Event Reporting System and JMDC insurance claims revealed that acetaminophen prevented the dyskinesia induced by dopamine D2 receptor antagonists. In vivo experiments further showed that a 21-day treatment with haloperidol increased the number of vacuous chewing movements (VCMs) in rats, an effect that was inhibited by oral acetaminophen treatment or intracerebroventricular injection of N-(4-hydroxyphenyl)-arachidonylamide (AM404), an acetaminophen metabolite that acts as an activator of the transient receptor potential vanilloid 1 (TRPV1). In mice, haloperidol-induced VCMs were also mitigated by treatment with AM404 applied to the dorsal striatum, an effect not seen in TRPV1-deficient mice. Acetaminophen prevented the haloperidol-induced decrease in the number of c-Fos+preproenkephalin+ striatal neurons in wild-type mice but not in TRPV1-deficient mice. Finally, chemogenetic stimulation of indirect pathway medium spiny neurons in the dorsal striatum decreased haloperidol-induced VCMs. These results suggest that acetaminophen activates the indirect pathway neurons by activating TRPV1 channels via AM404.

UI MeSH Term Description Entries
D008297 Male Males
D008810 Mice, Inbred C57BL One of the first INBRED MOUSE STRAINS to be sequenced. This strain is commonly used as genetic background for transgenic mouse models. Refractory to many tumors, this strain is also preferred model for studying role of genetic variations in development of diseases. Mice, C57BL,Mouse, C57BL,Mouse, Inbred C57BL,C57BL Mice,C57BL Mice, Inbred,C57BL Mouse,C57BL Mouse, Inbred,Inbred C57BL Mice,Inbred C57BL Mouse
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D004409 Dyskinesia, Drug-Induced Abnormal movements, including HYPERKINESIS; HYPOKINESIA; TREMOR; and DYSTONIA, associated with the use of certain medications or drugs. Muscles of the face, trunk, neck, and extremities are most commonly affected. Tardive dyskinesia refers to abnormal hyperkinetic movements of the muscles of the face, tongue, and neck associated with the use of neuroleptic agents (see ANTIPSYCHOTIC AGENTS). (Adams et al., Principles of Neurology, 6th ed, p1199) Dyskinesia, Medication-Induced,Medication-Induced Dyskinesia,Drug-Induced Dyskinesia,Drug-Induced Dyskinesias,Dyskinesia, Drug Induced,Dyskinesia, Medication Induced,Dyskinesias, Drug-Induced,Dyskinesias, Medication-Induced,Medication Induced Dyskinesia,Medication-Induced Dyskinesias
D000082 Acetaminophen Analgesic antipyretic derivative of acetanilide. It has weak anti-inflammatory properties and is used as a common analgesic, but may cause liver, blood cell, and kidney damage. Acetamidophenol,Hydroxyacetanilide,Paracetamol,APAP,Acamol,Acephen,Acetaco,Acetominophen,Algotropyl,Anacin-3,Datril,N-(4-Hydroxyphenyl)acetanilide,N-Acetyl-p-aminophenol,Panadol,Tylenol,p-Acetamidophenol,p-Hydroxyacetanilide,Anacin 3,Anacin3
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D017208 Rats, Wistar A strain of albino rat developed at the Wistar Institute that has spread widely at other institutions. This has markedly diluted the original strain. Wistar Rat,Rat, Wistar,Wistar Rats
D050916 TRPV Cation Channels A subgroup of TRP cation channels named after the vanilloid receptor. They are very sensitive to TEMPERATURE; hot spicy food, and CAPSAICIN. They contain a TRP domain (a five-turn amphipathic helix with an invariant TRYPTOPHAN) and ANKYRIN repeats. Selectivity for CALCIUM over SODIUM ranges from 3 to 100 fold. Capsaicin Receptor,Vanilloid Receptor,Capsaicin Receptors,Vanilloid Receptors,Cation Channels, TRPV,Channels, TRPV Cation,Receptor, Capsaicin,Receptor, Vanilloid,Receptors, Capsaicin,Receptors, Vanilloid
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus
D051381 Rats The common name for the genus Rattus. Rattus,Rats, Laboratory,Rats, Norway,Rattus norvegicus,Laboratory Rat,Laboratory Rats,Norway Rat,Norway Rats,Rat,Rat, Laboratory,Rat, Norway,norvegicus, Rattus

Related Publications

Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
January 1988, Psychopharmacology,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
January 2023, Journal of pharmacological sciences,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
April 2001, European journal of pharmacology,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
November 2013, Addiction biology,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
November 1989, Journal of neurology, neurosurgery, and psychiatry,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
January 1999, Neuroscience,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
December 1991, European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
January 2022, Frontiers in neuroscience,
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
January 2017, Cerebral cortex (New York, N.Y. : 1991),
Koki Nagaoka, and Takuya Nagashima, and Nozomi Asaoka, and Hiroki Yamamoto, and Chihiro Toda, and Gen Kayanuma, and Soni Siswanto, and Yasuhiro Funahashi, and Keisuke Kuroda, and Kozo Kaibuchi, and Yasuo Mori, and Kazuki Nagayasu, and Hisashi Shirakawa, and Shuji Kaneko
February 1992, Lancet (London, England),
Copied contents to your clipboard!